Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas

Structure of the human Nac1 POZ domain

(2009) Mark A. Stead et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells

(2009) Thomas W. Grunt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The C-terminal Pentapeptide of Nanog Tryptophan Repeat Domain Interacts with Nac1 and Regulates Stem Cell Proliferation but Not Pluripotency

(2009) Tianhua Ma et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation

(2009) D. T. Coleman et al.   MOLECULAR CANCER THERAPEUTICS

NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway

(2009) N Jinawath et al.   ONCOGENE

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells

(2008) Min-Young Lee et al.   BIOCHEMICAL JOURNAL

BEN: a novel domain in chromatin factors and DNA viral proteins

(2008) Saraswathi Abhiman et al.   BIOINFORMATICS

Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1

(2008) E. Furuta et al.   CANCER RESEARCH

An Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells

(2008) Jonghwan Kim et al.   CELL

Expanding the Roles for Pregnane X Receptor in Cancer: Proliferation and Drug Resistance in Ovarian Cancer

(2008) D. Gupta et al.   CLINICAL CANCER RESEARCH

Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors

(2008) H. Orita et al.   CLINICAL CANCER RESEARCH

A BTB/POZ Gene, NAC-1, a Tumor Recurrence-Associated Gene, as a Potential Target for Taxol Resistance in Ovarian Cancer

(2008) M. Ishibashi et al.   CLINICAL CANCER RESEARCH

Role of microRNAs in drug-resistant ovarian cancer cells

(2008) Antonio Sorrentino et al.   GYNECOLOGIC ONCOLOGY

Fatty Acid Synthase and AKT Pathway Signaling in a Subset of Papillary Thyroid Cancers

(2008) Shahab Uddin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reversal of Drug Resistance in Ovarian Cancer: Where Do We Go From Here?

(2008) Stan B. Kaye   JOURNAL OF CLINICAL ONCOLOGY

Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer

(2008) Michelangelo Fiorentino et al.   LABORATORY INVESTIGATION

Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death

(2008) J. L. Little et al.   MOLECULAR CANCER THERAPEUTICS

A new mechanism of drug resistance in breast cancer cells: fatty acid synthase overexpression-mediated palmitate overproduction

(2008) H. Liu et al.   MOLECULAR CANCER THERAPEUTICS

NAC1, a POZ/BTB protein that functions as a corepressor

(2008) Laxminarayana Korutla et al.   NEUROCHEMISTRY INTERNATIONAL

Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance

(2007) R. SALANI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER